Dysregulating ClpP
From Antibiotics to Anticancer?
- authored by
- David A. Dougan, Ingo Hantke, Kürşad Turgay
- Abstract
In this issue of Cell Chemical Biology, Wong et al. (2018) identify several dysregulators of a key mitochondrial protease: casein lytic protease P (ClpP). These dysregulators were found to trigger programmed cell death and may offer fresh avenues for the development of novel cancer therapeutics.
- Organisation(s)
-
Institute of Microbiology
- External Organisation(s)
-
La Trobe University
- Type
- Survey paper
- Journal
- Cell Chemical Biology
- Volume
- 25
- Pages
- 929-930
- No. of pages
- 2
- ISSN
- 2451-9456
- Publication date
- 16.08.2018
- Publication status
- Published
- Peer reviewed
- Yes
- ASJC Scopus subject areas
- Drug Discovery, Molecular Medicine, Molecular Biology, Biochemistry, Clinical Biochemistry, Pharmacology
- Sustainable Development Goals
- SDG 3 - Good Health and Well-being
- Electronic version(s)
-
https://doi.org/10.1016/j.chembiol.2018.08.002 (Access:
Open)
